tiprankstipranks
ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ:ACAD
US Market
ACAD
ACADIA Pharmaceuticals
RESEARCH TOOLSreports
Want to see ACAD full AI Analyst Report?

ACADIA Pharmaceuticals (ACAD) Ratios

2,439 Followers

ACADIA Pharmaceuticals Ratios

ACAD's free cash flow for Q1 2026 was $0.91. For the 2026 fiscal year, ACAD's free cash flow was decreased by $ and operating cash flow was $-0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.59 3.83 2.38 2.42 4.04
Quick Ratio
 3.48 3.71 2.32 2.28 3.99
Cash Ratio
 0.92 0.64 0.81 0.74 0.91
Solvency Ratio
 1.07 1.16 0.53 -0.18 -1.14
Operating Cash Flow Ratio
 0.40 0.40 0.40 0.07 -0.91
Short-Term Operating Cash Flow Coverage
 10.47 9.44 0.00 1.78 0.00
Net Current Asset Value
$ 738.85M$ 725.31M$ 483.36M$ 298.92M$ 320.54M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.04 0.08 0.11
Debt-to-Equity Ratio
 0.04 0.04 0.07 0.13 0.15
Debt-to-Capital Ratio
 0.04 0.04 0.07 0.12 0.13
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.29 1.27 1.62 1.73 1.47
Debt Service Coverage Ratio
 30.96 33.61 0.00 -8.30 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.00 <0.01 0.00
Interest Debt Per Share
 0.30 0.31 0.31 0.35 0.38
Net Debt to EBITDA
 -2.21 -0.90 -2.67 1.94 0.24
Profitability Margins
Gross Profit Margin
91.47%91.69%91.46%93.70%98.03%
EBIT Margin
9.01%12.96%8.80%-10.10%-43.23%
EBITDA Margin
9.55%12.96%10.46%-9.34%-42.84%
Operating Profit Margin
7.39%9.78%24.10%-10.10%-43.23%
Pretax Profit Margin
10.51%12.96%26.94%-7.03%-41.27%
Net Profit Margin
34.30%36.49%23.64%-8.44%-41.76%
Continuous Operations Profit Margin
34.30%36.49%23.64%-8.44%-41.76%
Net Income Per EBT
326.35%281.49%87.75%120.08%101.19%
EBT Per EBIT
142.27%132.53%111.82%69.55%95.46%
Return on Assets (ROA)
23.40%25.00%19.07%-8.18%-36.74%
Return on Equity (ROE)
35.65%31.86%30.90%-14.19%-53.94%
Return on Capital Employed (ROCE)
6.22%8.14%29.11%-14.83%-48.38%
Return on Invested Capital (ROIC)
6.17%8.07%25.22%-14.56%-47.42%
Return on Tangible Assets
25.06%26.87%21.20%-8.97%-36.74%
Earnings Yield
10.65%8.64%7.45%-1.19%-8.39%
Efficiency Ratios
Receivables Turnover
 8.09 7.23 9.15 7.10 8.20
Payables Turnover
 7.63 8.16 5.05 2.61 0.80
Inventory Turnover
 2.96 2.57 3.73 1.28 1.53
Fixed Asset Turnover
 17.98 19.53 18.86 12.86 8.40
Asset Turnover
 0.68 0.69 0.81 0.97 0.88
Working Capital Turnover Ratio
 1.39 1.61 2.12 1.95 1.14
Cash Conversion Cycle
 120.64 147.97 65.57 197.30 -174.86
Days of Sales Outstanding
 45.11 50.49 39.90 51.43 44.51
Days of Inventory Outstanding
 123.39 142.19 97.89 285.89 238.26
Days of Payables Outstanding
 47.86 44.72 72.21 140.02 457.63
Operating Cycle
 168.50 192.68 137.79 337.31 282.77
Cash Flow Ratios
Operating Cash Flow Per Share
 0.72 0.65 0.95 0.10 -0.71
Free Cash Flow Per Share
 1.25 0.62 0.95 -0.14 -0.71
CapEx Per Share
 0.52 0.03 <0.01 0.24 0.00
Free Cash Flow to Operating Cash Flow
 1.72 0.96 1.00 -1.40 1.00
Dividend Paid and CapEx Coverage Ratio
 1.39 23.42 301.57 0.42 0.00
Capital Expenditure Coverage Ratio
 1.39 23.42 301.57 0.42 0.00
Operating Cash Flow Coverage Ratio
 2.43 2.10 3.03 0.29 -1.84
Operating Cash Flow to Sales Ratio
 0.11 0.10 0.16 0.02 -0.22
Free Cash Flow Yield
6.00%2.32%5.17%-0.46%-4.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 9.39 11.57 13.43 -83.69 -11.92
Price-to-Sales (P/S) Ratio
 3.23 4.22 3.17 7.06 4.98
Price-to-Book (P/B) Ratio
 2.83 3.69 4.15 11.88 6.43
Price-to-Free Cash Flow (P/FCF) Ratio
 16.68 43.02 19.34 -219.68 -22.57
Price-to-Operating Cash Flow Ratio
 28.57 41.18 19.28 307.10 -22.57
Price-to-Earnings Growth (PEG) Ratio
 0.15 0.17 -0.03 1.16 -0.43
Price-to-Fair Value
 2.83 3.69 4.15 11.88 6.43
Enterprise Value Multiple
 31.67 31.66 27.69 -73.68 -11.38
Enterprise Value
 3.31B 4.40B 2.77B 5.00B 2.52B
EV to EBITDA
 31.67 31.66 27.69 -73.68 -11.38
EV to Sales
 3.02 4.10 2.90 6.88 4.87
EV to Free Cash Flow
 15.59 41.82 17.64 -214.05 -22.11
EV to Operating Cash Flow
 26.81 40.04 17.58 299.23 -22.11
Tangible Book Value Per Share
 6.70 6.61 3.70 2.24 2.48
Shareholders’ Equity Per Share
 7.32 7.25 4.42 2.64 2.48
Tax and Other Ratios
Effective Tax Rate
 -2.26 -1.81 0.12 -0.20 -0.01
Revenue Per Share
 6.42 6.33 5.78 4.43 3.20
Net Income Per Share
 2.20 2.31 1.37 -0.37 -1.34
Tax Burden
 3.26 2.81 0.88 1.20 1.01
Interest Burden
 1.17 1.00 3.06 0.70 0.95
Research & Development to Revenue
 0.30 0.31 0.32 0.48 0.70
SG&A to Revenue
 0.54 0.51 0.51 0.54 0.00
Stock-Based Compensation to Revenue
 0.03 0.00 0.07 0.09 0.13
Income Quality
 0.33 0.28 0.70 -0.27 0.53
Currency in USD